BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -15.33 Million USD | -22.77% |
| 2021 | -8.1 Million USD | -112.65% |
| 2020 | -3.81 Million USD | -122.54% |
| 2019 | -1.71 Million USD | 89.15% |
| 2018 | -15.79 Million USD | -1221.57% |
| 2017 | -1.19 Million USD | 19.25% |
| 2016 | -1.48 Million USD | -130.97% |
| 2015 | -640.78 Thousand USD | -70.33% |
| 2014 | -376.19 Thousand USD | -197.41% |
| 2013 | 386.19 Thousand USD | -31.81% |
| 2012 | 566.33 Thousand USD | -79.16% |
| 2011 | 2.71 Million USD | -51.49% |
| 2010 | 5.6 Million USD | 2.15% |
| 2009 | 5.48 Million USD | 57.78% |
| 2008 | 3.47 Million USD | 69.29% |
| 2007 | 2.05 Million USD | 75.66% |
| 2006 | 1.16 Million USD | 435.1% |
| 2005 | -348.86 Thousand USD | -11.29% |
| 2004 | -313.46 Thousand USD | -8.87% |
| 2003 | -287.91 Thousand USD | 11.94% |
| 2002 | -326.97 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | 580.74 Thousand USD | 107.84% |
| 2023 Q2 | 1.29 Million USD | 123.75% |
| 2023 Q3 | -3.14 Million USD | -342.39% |
| 2022 Q4 | -7.41 Million USD | -139.66% |
| 2022 FY | -9.95 Million USD | -22.77% |
| 2022 Q3 | -3.09 Million USD | -11.76% |
| 2022 Q1 | -2.55 Million USD | 19.37% |
| 2022 Q2 | -2.76 Million USD | -8.22% |
| 2021 Q2 | -150.44 Thousand USD | 95.36% |
| 2021 Q1 | -3.24 Million USD | -291.18% |
| 2021 FY | -8.1 Million USD | -112.65% |
| 2021 Q3 | -1.54 Million USD | -927.18% |
| 2021 Q4 | -3.17 Million USD | -105.18% |
| 2020 Q1 | -1.78 Million USD | -814.86% |
| 2020 Q3 | -1.43 Million USD | 30.92% |
| 2020 Q4 | 1.69 Million USD | 218.3% |
| 2020 FY | -3.81 Million USD | -122.54% |
| 2020 Q2 | -2.07 Million USD | -16.1% |
| 2019 Q1 | -373.48 Thousand USD | 97.26% |
| 2019 FY | -1.71 Million USD | 89.15% |
| 2019 Q4 | -195.25 Thousand USD | 54.79% |
| 2019 Q3 | -431.91 Thousand USD | 39.37% |
| 2019 Q2 | -712.42 Thousand USD | -90.75% |
| 2018 FY | -15.79 Million USD | -1221.57% |
| 2018 Q1 | -416.69 Thousand USD | -19.14% |
| 2018 Q2 | -1.54 Million USD | -270.45% |
| 2018 Q3 | -224.7 Thousand USD | 85.44% |
| 2018 Q4 | -13.6 Million USD | -5956.27% |
| 2017 FY | -1.19 Million USD | 19.25% |
| 2017 Q2 | -162.24 Thousand USD | 52.66% |
| 2017 Q1 | -342.75 Thousand USD | 35.74% |
| 2017 Q3 | -340.33 Thousand USD | -109.77% |
| 2017 Q4 | -349.73 Thousand USD | -2.76% |
| 2016 Q2 | -192.5 Thousand USD | 57.78% |
| 2016 FY | -1.48 Million USD | -130.97% |
| 2016 Q1 | -455.9 Thousand USD | 36.42% |
| 2016 Q4 | -533.37 Thousand USD | -78.83% |
| 2016 Q3 | -298.26 Thousand USD | -54.94% |
| 2015 Q1 | 4242.00 USD | 100.76% |
| 2015 Q3 | 81.45 Thousand USD | 965.51% |
| 2015 FY | -640.78 Thousand USD | -70.33% |
| 2015 Q4 | -717.06 Thousand USD | -980.35% |
| 2015 Q2 | -9411.00 USD | -321.85% |
| 2014 Q1 | -4807.00 USD | 96.81% |
| 2014 FY | -376.19 Thousand USD | -197.41% |
| 2014 Q2 | -291.97 Thousand USD | -5973.95% |
| 2014 Q4 | -560.58 Thousand USD | -216.5% |
| 2014 Q3 | 481.16 Thousand USD | 264.8% |
| 2013 Q2 | 173.47 Thousand USD | 77.22% |
| 2013 Q3 | 265.74 Thousand USD | 53.19% |
| 2013 Q4 | -150.91 Thousand USD | -156.79% |
| 2013 Q1 | 97.88 Thousand USD | 4.94% |
| 2013 FY | 386.19 Thousand USD | -31.81% |
| 2012 Q3 | 98.79 Thousand USD | -56.97% |
| 2012 FY | 566.33 Thousand USD | -79.16% |
| 2012 Q4 | 93.27 Thousand USD | -5.58% |
| 2012 Q1 | 144.67 Thousand USD | -89.63% |
| 2012 Q2 | 229.58 Thousand USD | 58.68% |
| 2011 Q3 | 172.52 Thousand USD | -74.59% |
| 2011 Q1 | 471.72 Thousand USD | -37.44% |
| 2011 FY | 2.71 Million USD | -51.49% |
| 2011 Q4 | 1.39 Million USD | 708.47% |
| 2011 Q2 | 678.87 Thousand USD | 43.91% |
| 2010 FY | 5.6 Million USD | 2.15% |
| 2010 Q1 | 506.96 Thousand USD | -67.32% |
| 2010 Q2 | 1.8 Million USD | 256.94% |
| 2010 Q3 | 2.53 Million USD | 39.96% |
| 2010 Q4 | 753.99 Thousand USD | -70.23% |
| 2009 Q1 | 485.44 Thousand USD | -40.62% |
| 2009 Q2 | 956.09 Thousand USD | 96.95% |
| 2009 Q3 | 2.49 Million USD | 160.65% |
| 2009 Q4 | 1.55 Million USD | -37.75% |
| 2009 FY | 5.48 Million USD | 57.78% |
| 2008 Q1 | 575.4 Thousand USD | -21.38% |
| 2008 Q4 | 817.5 Thousand USD | -22.61% |
| 2008 Q3 | 1.05 Million USD | 1.43% |
| 2008 Q2 | 1.04 Million USD | 80.99% |
| 2008 FY | 3.47 Million USD | 69.29% |
| 2007 Q4 | 731.88 Thousand USD | 26.96% |
| 2007 Q2 | 832.52 Thousand USD | 1052.12% |
| 2007 Q1 | -87.43 Thousand USD | -105.49% |
| 2007 FY | 2.05 Million USD | 75.66% |
| 2007 Q3 | 576.49 Thousand USD | -30.75% |
| 2006 Q2 | -72.24 Thousand USD | 15.94% |
| 2006 Q3 | -256.16 Thousand USD | -254.57% |
| 2006 Q4 | 1.59 Million USD | 721.63% |
| 2006 FY | 1.16 Million USD | 435.1% |
| 2006 Q1 | -85.94 Thousand USD | -340.32% |
| 2005 Q4 | -19.51 Thousand USD | 85.79% |
| 2005 FY | -348.86 Thousand USD | -11.29% |
| 2005 Q3 | -137.31 Thousand USD | -61.13% |
| 2005 Q1 | -82.8 Thousand USD | 5.13% |
| 2005 Q2 | -85.22 Thousand USD | -2.92% |
| 2004 Q3 | -93.4 Thousand USD | -17.68% |
| 2004 Q1 | -53.4 Thousand USD | 38.51% |
| 2004 Q2 | -79.37 Thousand USD | -48.63% |
| 2004 FY | -313.46 Thousand USD | -8.87% |
| 2004 Q4 | -87.28 Thousand USD | 6.56% |
| 2003 FY | -287.91 Thousand USD | 11.94% |
| 2003 Q4 | -86.85 Thousand USD | -77.75% |
| 2003 Q3 | -48.86 Thousand USD | 51.56% |
| 2003 Q1 | -51.32 Thousand USD | 45.2% |
| 2003 Q2 | -100.87 Thousand USD | -96.54% |
| 2002 Q2 | -77.91 Thousand USD | 23.55% |
| 2002 FY | -326.97 Thousand USD | 0.0% |
| 2002 Q3 | -53.47 Thousand USD | 31.38% |
| 2002 Q1 | -101.91 Thousand USD | 0.0% |
| 2002 Q4 | -93.66 Thousand USD | -75.17% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -13.47 Million USD | -13.808% |
| China Jo-Jo Drugstores, Inc. | -3.53 Million USD | -333.956% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 2744.561% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | 3658.806% |
| Leafly Holdings, Inc. | -7.05 Million USD | -117.536% |
| Leafly Holdings, Inc. | -7.05 Million USD | -117.536% |
| LifeMD, Inc. | -14.48 Million USD | -5.861% |
| LifeMD, Inc. | -14.48 Million USD | -5.861% |
| TRxADE HEALTH, Inc. | -7.26 Million USD | -111.174% |
| PetMed Express, Inc. | -8.16 Million USD | -87.925% |
| Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 99.891% |